M O 5 (Oxybutynin chloride extended release 5 mg)

Pill imprint M O 5 has been identified as Oxybutynin chloride extended release 5 mg.

Oxybutynin is used in the treatment of overactive bladder; urinary incontinence; hyperhidrosis; dysuria; prostatitis and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M O 5

Oxybutynin chloride extended release 5 mg M O 5
Oxybutynin chloride extended release 5 mg M O 5  Front
Oxybutynin chloride extended release 5 mg M O 5  Back
Oxybutynin chloride extended release 5 mg M O 5
Oxybutynin chloride extended release
Imprint:
M O 5
Strength:
5 mg
Color:
Green
Size:
8.00 mm
Shape:
Round
Availability:
Rx and/or OTC
Drug Class:
Urinary antispasmodics
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-6605
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0722 UDL Laboratories Inc
16590-0321 Stat RX USA LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)